Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 PR Newswire CUPERTINO, Calif., Jan. 27, 2011 CUPERTINO, Calif., Jan. 27, 2011 /PRNewswire/ -- DURECT...
Zacks Analyst Blog Highlights: Pfizer, King Pharmaceuticals, Durect Pharma, Pain Therapeutics and Acura Pharmaceuticals PR Newswire CHICAGO, Jan. 25, 2011 CHICAGO, Jan. 25, 2011 /PRNewswire/...
BRISTOL, Tenn. and SAN MATEO, Calif., Dec. 27, 2010 (GLOBE NEWSWIRE) -- King Pharmaceuticals®, Inc. (NYSE:KG) and Pain Therapeutics®, Inc. (Nasdaq:PTIE) today announced that King has resubmitted...
REMOXY® New Drug Application Resubmitted PR Newswire CUPERTINO, Calif., Dec. 27, 2010 CUPERTINO, Calif., Dec. 27, 2010 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) today reported...
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® PR Newswire BRISTOL, Tenn. and SAN MATEO, Calif., Dec. 27, 2010 BRISTOL, Tenn. and SAN MATEO...
King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® Tablets PR Newswire BRISTOL, Tenn. and PALATINE, Ill., Dec. 20, 2010 BRISTOL, Tenn. and...
Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc. PR Newswire NEW YORK, Dec. 15, 2010 NEW YORK, Dec. 15, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) today announced...
Standard & Poor's Announces Changes to U.S. Indices PR Newswire NEW YORK, Dec. 9, 2010 NEW YORK, Dec. 9, 2010 /PRNewswire/ -- S&P will make the following changes to the S&P 500, S&P MidCap 400...
Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc. PR Newswire NEW YORK, Oct. 22 NEW YORK, Oct. 22 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) today...
The Law Office of Abe Shainberg is investigating the Board of Directors of King Pharmaceuticals, Inc. (NYSE:KG) for possible breaches of fiduciary duty and other violations of...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
